Repositorio
Institucional

Harapan, Harapan

Anwar, Samsul

Yufika, Amanda

Sharun, Khan

Gachabayov, Mahir

Fahriani, Marhami

Husnah, Milda

Raad, Rawan

Abdalla, Rashed Y. A.

Adam, Rashed Y.

Khiri, Namareg M. E.

Ismaeil, Mohajer I. H.

Ismail, Asma Y.

Kacem, Wajdi

Dahman, Nesrine B. H.

Teyeb, Zeineb

Aloui, Khaoula

Hafsi, Montacer

Ferjani, Manel

Deeb, Dalia A.

Emad, Dina

Abbas, Kirellos Said

Monib, Fatma A.

Sami, Farah S.

Subramaniam, R.

Panchawagh, Suhrud

Anandu, Sunil

Haque, Md Ariful

Ferreto, Lirane E. D.

Briones, Maria F. C.

Morales, Rocio B., I

Diaz, Sebastian A. L.

Aburto, Jose T. O.

Rojas, Jorge E. T.

Balogun, Emmanuel O.

Enitan, Seyi S.

Yomi, Akele R.

Durosinmi, Abiodun

Ezigbo, Eyiuche D.

Adejumo, Esther N.

Babadi, Elham

Kakemam, Edris

Malik, Najma, I

Ullah, Irfan

Rosiello, Dott F.

Emran, Talha B.

Wendt, Guilherme W.

Arab-Zozani, Morteza

Wagner, Abram L.

Mudatsir, Mudatsir

Vaccine hesitancy among communities in ten countries in Asia, Africa, and South America during the COVID-19 pandemic

TAYLOR & FRANCIS LTD

PATHOGENS AND GLOBAL HEALTH

en

Vaccine hesitancy is considered one of the greatest threats to the ongoing coronavirus disease 2019 (COVID-19) vaccination programs. Lack of trust in vaccine benefits, along with concerns about side effects of the newly developed COVID-19 vaccine, might significantly contribute to COVID-19 vaccine hesitancy. The objective of this study was to determine the level of vaccine hesitancy among communities in particular their belief in vaccination benefits and perceived risks of new vaccines. An online cross-sectional study was conducted in 10 countries in Asia, Africa, and South America from February to May 2021. Seven items from the WHO SAGE Vaccine Hesitancy Scale were used to measure a construct of belief in vaccination benefit, and one item measured perceived riskiness of new vaccines. A logistic regression was used to determine which sociodemographic factors were associated with both vaccine hesitancy constructs. A total of 1,832 respondents were included in the final analysis of which 36.2% (range 5.6-52.2%) and 77.6% (range 38.3-91.2%) of them were classified as vaccine hesitant in terms of beliefs in vaccination benefits and concerns about new vaccines, respectively. Respondents from Pakistan had the highest vaccine hesitancy while those from Chile had the lowest. Being females, Muslim, having a non-healthcare-related job and not receiving a flu vaccination during the past 12 months were associated with poor beliefs of vaccination benefits. Those who were living in rural areas, Muslim, and those who did not received a flu vaccination during the past 12 months had relatively higher beliefs that new vaccines are riskier. High prevalence of vaccine hesitancy in some countries during the COVID-19 pandemic might hamper COVID-19 vaccination programs worldwide. Programs should be developed to promote vaccination in those sociodemographic groups with relatively high vaccine hesitancy.

artículo original

10.1080/20477724.2021.2011580

PDF

COVID-19

vaccine hesitancy

vaccine hesitant

vaccine acceptance

Who Sage

THREAT

Salud Pública

Ambiental y Ocupacional

Parasitología

Medicina Tropical

COVID-19

vacilación sobre las vacunas

aceptación de las vacunas

Who Sage

AMENAZA

Salud Pública y Ambiental

Enfermedades Infecciosas

Epidemiología

Vaccine hesitancy among communities in ten countries in Asia, Africa, and South America during the COVID-19 pandemic

236

243

artículo original

version publicada

0

metadata

metadata

https://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC9132408&blobtype=pdf

WOS:000733806400001